ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 513 filers reported holding ASTRAZENECA PLC in Q4 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $190,260,000 | +17.0% | 2,439,535 | +1.7% | 0.04% | +16.2% |
Q1 2024 | $162,553,000 | +2.7% | 2,399,321 | +2.1% | 0.04% | 0.0% |
Q4 2023 | $158,315,000 | +1.5% | 2,350,626 | +2.0% | 0.04% | -11.9% |
Q3 2023 | $156,040,000 | -11.5% | 2,304,193 | -6.4% | 0.04% | -8.7% |
Q2 2023 | $176,259,000 | +10.7% | 2,462,750 | +7.3% | 0.05% | +2.2% |
Q1 2023 | $159,240,000 | +10.2% | 2,294,176 | +7.7% | 0.04% | +9.8% |
Q4 2022 | $144,445,000 | +12.8% | 2,130,454 | -8.7% | 0.04% | +2.5% |
Q3 2022 | $128,018,000 | -18.5% | 2,334,370 | -1.9% | 0.04% | -13.0% |
Q2 2022 | $157,143,000 | -1.6% | 2,378,409 | -1.2% | 0.05% | +15.0% |
Q1 2022 | $159,746,000 | +11.3% | 2,408,000 | -2.3% | 0.04% | +21.2% |
Q4 2021 | $143,542,000 | -5.1% | 2,464,222 | -2.2% | 0.03% | -17.5% |
Q3 2021 | $151,312,000 | +28.0% | 2,519,325 | +27.6% | 0.04% | +29.0% |
Q2 2021 | $118,234,000 | +16.2% | 1,973,863 | -3.6% | 0.03% | +3.3% |
Q1 2021 | $101,764,000 | +2.9% | 2,046,742 | +3.4% | 0.03% | +3.4% |
Q4 2020 | $98,924,000 | -0.0% | 1,978,909 | +9.6% | 0.03% | -17.1% |
Q3 2020 | $98,936,000 | +3.7% | 1,805,393 | +0.1% | 0.04% | -7.9% |
Q2 2020 | $95,413,000 | +20.4% | 1,803,970 | +1.7% | 0.04% | 0.0% |
Q1 2020 | $79,241,000 | -4.3% | 1,774,350 | +6.8% | 0.04% | +26.7% |
Q4 2019 | $82,836,000 | +15.1% | 1,661,390 | +2.9% | 0.03% | +7.1% |
Q3 2019 | $71,953,000 | +7.3% | 1,614,377 | -0.6% | 0.03% | +3.7% |
Q2 2019 | $67,056,000 | -5.9% | 1,624,457 | -7.8% | 0.03% | -10.0% |
Q1 2019 | $71,269,000 | -12.2% | 1,762,787 | -17.5% | 0.03% | -23.1% |
Q4 2018 | $81,131,000 | -7.9% | 2,136,126 | -4.1% | 0.04% | +5.4% |
Q3 2018 | $88,133,000 | +3.7% | 2,227,270 | -8.0% | 0.04% | -2.6% |
Q2 2018 | $85,002,000 | -15.2% | 2,421,071 | -15.5% | 0.04% | -15.6% |
Q1 2018 | $100,250,000 | -1.7% | 2,866,728 | -2.4% | 0.04% | 0.0% |
Q4 2017 | $101,971,000 | +8.4% | 2,938,669 | +5.8% | 0.04% | 0.0% |
Q3 2017 | $94,093,000 | +48.8% | 2,777,219 | +49.7% | 0.04% | +36.4% |
Q2 2017 | $63,250,000 | +22.8% | 1,855,405 | +12.2% | 0.03% | +17.9% |
Q1 2017 | $51,489,000 | +55.5% | 1,653,520 | +36.4% | 0.03% | +55.6% |
Q4 2016 | $33,120,000 | -15.3% | 1,212,363 | +1.9% | 0.02% | -18.2% |
Q3 2016 | $39,081,000 | +82.7% | 1,189,364 | +67.9% | 0.02% | +69.2% |
Q2 2016 | $21,391,000 | +5.2% | 708,539 | -1.9% | 0.01% | 0.0% |
Q1 2016 | $20,339,000 | +2.1% | 722,283 | +23.1% | 0.01% | 0.0% |
Q4 2015 | $19,915,000 | +3.1% | 586,580 | -3.3% | 0.01% | -7.1% |
Q3 2015 | $19,308,000 | +62.1% | 606,778 | +224.5% | 0.01% | +75.0% |
Q2 2015 | $11,912,000 | +64.3% | 186,976 | +76.5% | 0.01% | +60.0% |
Q1 2015 | $7,248,000 | +0.9% | 105,910 | +3.8% | 0.01% | 0.0% |
Q4 2014 | $7,180,000 | +0.8% | 102,015 | +2.3% | 0.01% | 0.0% |
Q3 2014 | $7,123,000 | -18.3% | 99,707 | -15.0% | 0.01% | -16.7% |
Q2 2014 | $8,717,000 | -60.7% | 117,304 | -65.7% | 0.01% | -62.5% |
Q1 2014 | $22,205,000 | +22.7% | 342,250 | +12.3% | 0.02% | +23.1% |
Q4 2013 | $18,095,000 | +13.0% | 304,776 | -1.1% | 0.01% | +8.3% |
Q3 2013 | $16,012,000 | +26.3% | 308,314 | +15.0% | 0.01% | +9.1% |
Q2 2013 | $12,678,000 | – | 268,038 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |